Kenya Association of Pharmaceutical Industry (KAPI) is a membership organization representing manufacturers and local representatives that through research, invent and develop medicines and technologies that significantly improve people’s lives.

KAPI represents the industry to promote efficiency and access to medical products and healthcare technologies of the highest quality for diagnosis, health promotion, prevention and treatment of diseases. Intrinsic to KAPI’s mission is to forge partnerships with stakeholders to create the necessary enabling environment and systems to sustainably support care to patients.

In support of the Government’s role as the single largest provider of healthcare, KAPI member companies operating at local and global platforms offer access to critical medicines impacting HIV/AIDS, Malaria, TB, Immunisation, Maternal and Reproductive Health, Oncology and several Neglected Tropical Diseases (NTDs).

These health concerns disproportionally affect the poor and constitute the bulk of the top 10 mortality causes in Kenya. Further, it has supported establishment of institutional frameworks to advance and anchor Universal Healthcare Coverage (UHC) on a sustainable path through participation and inputs into pricing of medicines, collaborations with the parliamentary health committee, KAPI made input into the National Health Bill (2019) to ensure comprehensive listing and inclusion of all cadres of healthcare professionals, review of taxation and scheduling of medicines. These engagements serve to strengthen systems through appropriate policies and
guidelines.